Porteous v Pharmacy Board of Australia

Link copied
Case Copied 46 min read

QUEENSLAND CIVIL AND
ADMINISTRATIVE TRIBUNAL


CITATION:

Porteous v Pharmacy Board of Australia [2021] QCAT 286

PARTIES: REGINA PORTEOUS

(applicant)

v

PHARMACY BOARD OF AUSTRALIA

(respondent)

APPLICATION NO/S:

OCR246-20

MATTER TYPE:

Occupational regulation matters

DELIVERED ON:

27 September 2021

HEARING DATE:

19 – 20 August 2021

HEARD AT:

Brisbane

DECISION OF:

Judicial Member J Robertson

Assisted by:

Mr Kenneth Murphy
Dr Gail Neilson

Miss Hailie Uren

ORDERS:

1.       The immediate action taken by decision of the Board on 13 July 2020 is set aside.

2.       The parties are at liberty to file any submissions as to any matter arising out of these reasons within 14 days of the date of delivery of these reasons.

3.       Any matters to be determined as a result of any submissions filed in accordance with Order 2 shall be determined on the papers.

CATCHWORDS:

PROFESSIONS AND TRADES – HEALTH CARE PROFESSIONALS – PHARMACEUTICAL CHEMISTS – APPEALS – where the Board decided to take immediate action suspending the applicant’s registration – where the applicant sought a review of the Board’s decision – whether the applicant presents a serious risk to persons –where the conduct the subject of the immediate action essentially depends on the evidence of one witness, where the Tribunal had before it extensive material that was not before the Board - the limited role of the Tribunal in assessing the nature of relevant conduct and/or performance in a review of a decision to take immediate action -  whether the decision of the Board should be set aside

Health Practitioner Regulation National Law (Queensland), s 156, s 158

Queensland Civil and Administrative Tribunal Act 2009 (Qld), s 33

AMS v Medical Radiation Practice Board of Australia (No. 2) [2019] QCAT 401

Bernadt v Medical Board of Australia [2013] WASCA 259
Farshchi v Chinese Medicine Board of Australia (Review and Regulation) [2018] VCAT 1617

Gupta v Medical Board of Australia [2019] SAHPT 6

Health Ombudsman v Kirk [2019] QCAT 301

Ladhams v Medical Board of Australia (No 2) [2014] QCAT 286

Ord v Nursing and Midwifery Board of Australia (No. 2) [2015] QCAT 102
Peters v Medical Board of Australia [2020] QCAT 169
The Registrant v A Health Profession Board of Australia [2013] QCAT 485

WD v Medical Board of Australia [2013] QCAT 614

APPEARANCES & REPRESENTATION:

Applicant:

A Morris QC, instructed by Australian Law Partners

Respondent:

JR Green, instructed by Minter Ellison

REASONS FOR DECISION

Introduction

  1. The applicant Regina Porteous (Ms Porteous) is a registered pharmacist. She has been registered with the Board since 21 July 1987. She is the sole director of Lucaspharm Pty Ltd which owns a pharmacy in Morayfield known as the Morayfield Late Night Chemist (the Pharmacy).

  2. On 7 July 2020, Ms Porteous received notice from the Australian Health Practitioner Regulation Agency (AHPRA)[1] of proposed immediate action[2] to suspend her registration and inviting her to respond if she wished to make submissions. Ms Porteous provided two short written responses,[3] which, in effect, stated that the allegations that formed the basis of…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Porteous v Pharmacy Board of Australia and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2021] QCAT 286
Decision Date

CaseChat Overview and Summary

Ms Porteous has brought proceedings against the Pharmacy Board of Australia, seeking a review of a decision made by the Board. The Board's decision was based on a reasonable belief that Ms Porteous provided significant quantities of Schedule 8 and Schedule 4 medication and syringes to Ms D, a casual employee of the pharmacy and a patient who had not been prescribed any of the medication. Ms Porteous denies these allegations. The Board's decision was made pursuant to the Health Practitioner Regulation National Law (Qld).

The primary legal issue before the court was whether the Board's decision to refer the matter for investigation was reasonable, in light of the material before the Board. The court considered whether the Board had a reasonable belief that Ms Porteous had provided dangerous medications and large quantities of prescriptions to Ms D, and whether the Board's decision to refer the matter for investigation was therefore reasonable.

The court found that the Board's decision to refer the matter for investigation was reasonable, in light of the material before the Board. The court noted that the Board had a reasonable belief based on the information available to it, and that it was not the role of the Tribunal to reach conclusions on factual disputes. The court also found that it was not necessary for the Tribunal to reach any firm conclusions about the evidence of Ms Z and Ms D, as the Board had referred the matter for investigation and the investigation was ongoing.

The court dismissed the application and noted that the investigation referred to by the Board was ongoing.

Decision

Reasons for decision

In reality, she had no disciplinary history at all until the Panel’s decision of February 2014, although the conduct relating to that decision dated back seven and half years.The Board’s decision The decision notified to Ms Porteous on 13 July 2020 was based on the material then before the Board. The “information considered” is set out in the notice.[34] It is clear to me that the critical “factual” matters that informed the Board’s then held reasonable belief are set out in paragraph 3 of its reasons for decision which is set out above.[35][34]HB, Tab 2, page 25.[35]HB, Tab 2, page 21. In summary, the Board had a complaint that Ms Porteous had provided a significant quantity of Schedule 8 and Schedule 4 medication and syringes to Ms D, a casual employee of the pharmacy, and a patient who had not been prescribed any of the medication. The Inspectors had confirmed to AHPRA that both the notifier (Ms Z) and the consumer (Ms D) had been spoken to and “confirmed the allegations as made in the notification”. The Board had the photographs allegedly taken by Ms Z on her phone on 5 May, and confirmation from the Inspectors that they had seized the drugs and photographed them and photographed Ms Z’s phone. In the opinion of the Board “the risk (was) heightened” “in circumstances where (it was alleged) Ms Porteous also provided a large number of prescriptions to Ms D”. It is clear that the Board did not then have the transcript of the interviews undertaken between Inspectors and Ms Z and Ms D on 23 and 24 June 2020. Despite Ms Porteous’ vehement denials that she had supplied dangerous medications and/or large quantities of prescriptions to Ms D, the material before the Board was clearly sufficient to found a reasonable belief in terms of section 156(1)(a)(b) of the National Law.The proceedings before the Tribunal The Board, by reference to its actions, maintains its “reasonable belief”, taking into account all the additional material filed before the Tribunal. Clearly, as Mr Green was supporting the Board’s decision after the cross-examination of Ms Z and Ms D, the Board’s position is that it still then held such a belief. In my opinion, particularly in relation to the evidence of Ms Z, it is not necessary at this stage for the Tribunal to reach any firm conclusions about what she saw and did. It is not necessary, and at this point not open, to reach any conclusion in relation to Mr Morris’s primary submission that Ms Z and Ms D have colluded and conspired to make up what would indeed be a monstrous and complex lie by way of retribution against Ms Porteous, because of her conduct and the conduct of her staff towards them. In my opinion, this contention, made by Mr Morris in his closing address, is not borne out on the present state of the material before the Tribunal. As the decision notice itself notes, the Board decided to refer the matter for investigation under section 160(1) of the National Law. I was informed by Mr Green on 20 August that the investigation is ongoing. It is not the role of the Tribunal, in proceedings of this nature, to reach conclusions on factual disputes on the basis that the Board has some onus. Section 20 of the QCAT Act (read in conjunction with relevant sections of the National Law) sets out the role of the Tribunal at this stage to which reference is made earlier in these reasons.